Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.91% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.04% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Ryman Hospitality Properties
RHP
$7.82B
| $1.54M | ﹤0.01% |
41,812
-9,799
| -19% | -$347K |
|
|
ADAM
2302
Adamas Trust
ADAM
$913M
| $1.54M | ﹤0.01% |
150,587
+63,618
| +73% | +$663K |
|
2303
LiveRamp
RAMP
$2.3B
| $1.53M | ﹤0.01% |
29,635
-7,428
| -20% | -$371K |
|
|
AERI
2304
DELISTED
Aerie Pharmaceuticals
AERI
| $1.53M | ﹤0.01% |
130,355
-47,523
| -27% | -$579K |
|
2305
Axos Financial
AX
$5.68B
| $1.53M | ﹤0.01% |
65,640
+14,453
| +28% | +$330K |
|
2306
Gerdau
GGB
$9.48B
| $1.53M | ﹤0.01% |
520,985
-58,812
| -10% | -$161K |
|
|
RDS.B
2307
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.53M | ﹤0.01% |
63,134
-1,489
| -2% | -$42.7K |
|
2308
Acadia Realty Trust
AKR
$2.84B
| $1.53M | ﹤0.01% |
145,554
+23,083
| +19% | +$276K |
|
2309
CALL
Estee Lauder
EL
$31.6B
| $1.53M | ﹤0.01% |
7,000
-4,000
| -36% | -$823K |
|
2310
AZZ Inc
AZZ
$4.55B
| $1.53M | ﹤0.01% |
44,754
+6,806
| +18% | +$226K |
|
2311
Qfin Holdings
QFIN
$1.53B
| $1.52M | ﹤0.01% |
127,571
+79,071
| +163% | +$1.03M |
|
2312
FLEX LNG
FLNG
$1.6B
| $1.52M | ﹤0.01% |
264,890
-16,819
| -6% | -$93.3K |
|
|
UHT
2313
Universal Health Realty Income Trust
UHT
$573M
| $1.52M | ﹤0.01% |
26,628
+4,564
| +21% | +$308K |
|
2314
MGP Ingredients
MGPI
$381M
| $1.52M | ﹤0.01% |
38,179
+3,513
| +10% | +$131K |
|
2315
CALL
Sarepta Therapeutics
SRPT
$1.94B
| $1.52M | ﹤0.01% |
10,800
| – | – |
|
2316
CALL
Viatris
VTRS
$18.5B
| $1.52M | ﹤0.01% |
102,200
| – | – |
|
|
HTO
2317
H2O America
HTO
$2.65B
| $1.51M | ﹤0.01% |
24,885
-6,359
| -20% | -$402K |
|
2318
PUT
Agilent Technologies
A
$41.9B
| $1.51M | ﹤0.01% |
15,000
| – | – |
|
2319
CALL
International Paper
IP
$21.8B
| $1.51M | ﹤0.01% |
39,389
| – | – |
|
|
SAFE
2320
DELISTED
Safehold Inc.
SAFE
| $1.51M | ﹤0.01% |
24,344
-3,445
| -12% | -$187K |
|
2321
Encompass Health
EHC
$12.3B
| $1.51M | ﹤0.01% |
29,177
-14,662
| -33% | -$752K |
|
2322
CEVA Inc
CEVA
$855M
| $1.5M | ﹤0.01% |
38,195
+5,439
| +17% | +$216K |
|
2323
CALL
Avis
CAR
$4.93B
| $1.5M | ﹤0.01% |
57,100
| – | – |
|
2324
Acadia Healthcare
ACHC
$2.95B
| $1.5M | ﹤0.01% |
50,935
-70,054
| -58% | -$2.03M |
|
2325
Synaptics
SYNA
$4.3B
| $1.5M | ﹤0.01% |
18,647
-6,053
| -25% | -$478K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.